openPR Logo
Press release

Investigation for Long-Term Investors in shares of Lipocine Inc. (NASDAQ: LPCN) announced

03-24-2020 04:44 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Lipocine Inc. (NASDAQ: LPCN) shares.

An investigation on behalf of current long term investors in Lipocine Inc. (NASDAQ: LPCN) shares.

An investigation was announced for current long-term investors in shares of Lipocine Inc. (NASDAQ: LPCN) concerning potential breaches of fiduciary duties by certain directors of Lipocine Inc. was announced.

Investors who are current long term investors in Lipocine Inc. (NASDAQ: LPCN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: LPCN stocks follows a lawsuit filed against Lipocine Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: LPCN stocks, concerns whether certain Lipocine directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of Utah the plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that the results from Lipocine's clinical studies of TLANDO were insufficient to demonstrate the drug's efficacy, that accordingly, Lipocine's third NDA for TLANDO was highly likely to be found deficient by the FDA, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Lipocine Inc. (NASDAQ: LPCN) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Long-Term Investors in shares of Lipocine Inc. (NASDAQ: LPCN) announced here

News-ID: 1982414 • Views:

More Releases from Shareholders Foundation

Lawsuit filed for certain Investors who lost money with shares of Global Cord Blood Corporation (OTC: CORBF)
Lawsuit filed for certain Investors who lost money with shares of Global Cord Bl …
An investor, who purchased shares of Global Cord Blood Corporation (OTC: CORBF), filed a lawsuit over alleged violations of Federal Securities Laws by Global Cord Blood Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Global Cord Blood Corporation (OTC: CORBF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. OTC: CORBF investors should contact the Shareholders
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ: ADSK)
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ …
An investor, who purchased shares of Autodesk, Inc. (NASDAQ: ADSK), filed a lawsuit over alleged violations of Federal Securities Laws by Autodesk, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Autodesk, Inc. (NASDAQ: ADSK) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. NASDAQ: ADSK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Investors who lost money with shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) should contact the Shareholders Foundation in connection with pending lawsuit
Investors who lost money with shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) sho …
An investor, who purchased shares of AST SpaceMobile, Inc. (NASDAQ: ASTS), filed a lawsuit over alleged violations of Federal Securities Laws by AST SpaceMobile, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of AST SpaceMobile, Inc. (NASDAQ: ASTS) have certain options and for certain investors are short and strict deadlines running. Deadline: June 17, 2024. NASDAQ: ASTS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of Sharecare, Inc. (NASDAQ: SHCR)
Lawsuit filed for Investors who lost money with shares of Sharecare, Inc. (NASDA …
An investor, who purchased shares of Sharecare, Inc. (NASDAQ: SHCR), filed a lawsuit over alleged violations of Federal Securities Laws by Sharecare, Inc. Investors who purchased shares of Sharecare, Inc. (NASDAQ: SHCR) have certain options and for certain investors are short and strict deadlines running. Deadline: June 18, 2024. NASDAQ: SHCR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Atlanta, GA based Sharecare, Inc. operates as

All 5 Releases


More Releases for Lipocine

Targeted Delivery Drugs Market 2020 Showing Tremendous Growth With Top Players l …
Global targeted delivery drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of targeted delivery drugs market for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa. Global targeted delivery drugs market is expected to rise by 2026,
Latest Study on Targeted Delivery Drugs Market 2020 and Brief Analysis of Top Co …
Global Targeted Delivery Drugs Market Industry research report covers the industry overview with Market Size, Share, Growth, futuristic cost, revenue, demand and supply data. Targeted Delivery Drugs Industry research analysts provide an elaborate description of the value chain and its distributor analysis The Global Targeted Delivery Drugs Market -study provides comprehensive data which enhances the understanding, scope and application of this report. Get Sample Copy of This Report @ https://www.orianresearch.com/request-sample/1589596 Global Targeted
Complete analysis report of Topical Contraceptive Market with projected growth | …
Global Topical Contraceptive Market 2019-2026: Snapshot The Market Research Topical Contraceptive report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Topical Contraceptive market based on various segments. It also provides market size and forecast estimates from the year 2017 to 2026 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa
Deadline on January 14th in Lawsuit for Investors in Lipocine Inc. (NASDAQ: LPCN …
The Shareholders Foundation announced that a deadline is coming up on January 14, 2020 in the lawsuit filed for certain investors of Lipocine Inc. (NASDAQ: LPCN) over alleged securities laws violations by Lipocine Inc. Investors who purchased shares of Lipocine Inc. (NASDAQ: LPCN) have certain options and there are strict and short deadlines running. Deadline: January 14, 2020. NASDAQ: LPCN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Lawsuit filed for Investors in shares of Lipocine Inc. (NASDAQ: LPCN)
An investor, who purchased NASDAQ: LPCN shares , filed a lawsuit over alleged violations of Federal Securities Laws by Lipocine Inc. Investors who purchased shares of Lipocine Inc. (NASDAQ: LPCN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 14, 2020. NASDAQ: LPCN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Salt Lake City, UT based Lipocine Inc., a specialty
Future of Female Contraceptive Products Market – A comprehensive study by Key …
MarketResearchNest.com adds “Global Female Contraceptive Products Industry Market Research Report” new report to its research database. The report spread across 103 pages with multiple tables and figures in it. This report studies the Female Contraceptive Products market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers.